T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$8.01B |
| 2 |
Amazon
AMZN
|
+$5.64B |
| 3 |
Danaher
DHR
|
+$4.2B |
| 4 |
Gilead Sciences
GILD
|
+$4.09B |
| 5 |
JPMorgan Chase
JPM
|
+$4.03B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.58% |
| 5 | Technology | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLOG
1101
DELISTED
GASLOG LTD
GLOG
| $17.3M | ﹤0.01% |
+1,349,197
| New | +$17.3M |
|
1102
Qualys
QLYS
$6.47B
| $17.3M | ﹤0.01% |
+1,070,400
| New | +$13.9M |
|
1103
KLA
KLAC
$274B
| $17.2M | ﹤0.01% |
+3,086,050
| New | +$16.8M |
|
1104
Waters Corp
WAT
$40.9B
| $17.1M | ﹤0.01% |
+170,966
| New | +$16.4M |
|
1105
Korn Ferry
KFY
$4.28B
| $17.1M | ﹤0.01% |
+912,700
| New | +$15.6M |
|
1106
Preferred Bank
PFBC
$1.26B
| $17.1M | ﹤0.01% |
+1,035,457
| New | +$16.6M |
|
1107
Cytokinetics
CYTK
$10.5B
| $17.1M | ﹤0.01% |
+1,473,858
| New | +$11.6M |
|
1108
Xerox
XRX
$412M
| $17M | ﹤0.01% |
+711,028
| New | +$16.6M |
|
1109
Oil-Dri
ODC
$1.27B
| $17M | ﹤0.01% |
+1,236,812
| New | +$16.6M |
|
1110
Weyco Group
WEYS
$446M
| $17M | ﹤0.01% |
+672,970
| New | +$16.1M |
|
|
TTSH
1111
DELISTED
Tile Shop Holdings
TTSH
| $16.9M | ﹤0.01% |
+585,000
| New | +$14.8M |
|
1112
KeyCorp
KEY
$24.5B
| $16.7M | ﹤0.01% |
+1,514,747
| New | +$15.6M |
|
1113
Eastman Chemical
EMN
$8.29B
| $16.7M | ﹤0.01% |
+238,214
| New | +$16.6M |
|
1114
Rigel Pharmaceuticals
RIGL
$782M
| $16.6M | ﹤0.01% |
+496,460
| New | +$22.5M |
|
|
ACHN
1115
DELISTED
Achillion Pharmaceuticals
ACHN
| $16.6M | ﹤0.01% |
+2,023,400
| New | +$15.4M |
|
1116
Capital Southwest
CSWC
$1.6B
| $16.5M | ﹤0.01% |
+1,304,578
| New | +$15.4M |
|
1117
CTS Corp
CTS
$1.82B
| $16.5M | ﹤0.01% |
+1,209,750
| New | +$13.7M |
|
|
AREX
1118
DELISTED
Approach Resources Inc.
AREX
| $16.4M | ﹤0.01% |
+668,600
| New | +$16.7M |
|
1119
Teradata
TDC
$2.49B
| $16.4M | ﹤0.01% |
+326,086
| New | +$17.6M |
|
1120
Infosys
INFY
$50.3B
| $16.3M | ﹤0.01% |
+3,174,920
| New | +$17.3M |
|
|
NGD
1121
DELISTED
New Gold Inc
NGD
| $16.3M | ﹤0.01% |
+2,519,758
| New | +$18M |
|
|
BKYF
1122
DELISTED
BK KY FINL CORP
BKYF
| $16.2M | ﹤0.01% |
+570,620
| New | +$15M |
|
|
BSMX
1123
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $16.2M | ﹤0.01% |
+1,140,400
| New | +$17.8M |
|
|
PTRY
1124
DELISTED
PANTRY INC (THE)
PTRY
| $16.2M | ﹤0.01% |
+1,328,120
| New | +$17.6M |
|
1125
Healthcare Services Group
HCSG
$1.43B
| $16.2M | ﹤0.01% |
+659,645
| New | +$15.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for T. Rowe Price Associates, which disclosed 2,429 positions worth $374B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2013 buy was Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $374B portfolio in Q2 2013.
- T. Rowe Price Associates disclosed 2,429 positions in Q2 2013, its first 13F filing on record.
Based on T. Rowe Price Associates's 13F filing for Q2 2013, filed 14 Aug 2013.